Literature DB >> 7722160

Gender risk for anaphylactoid reaction to radiographic contrast media.

D M Lang1, M B Alpern, P F Visintainer, S T Smith.   

Abstract

BACKGROUND: Female predominance has been reported previously in series of anaphylaxis cases; however, no definite precedent has been established for greater risk of anaphylactoid reaction caused by contrast media infusion on the basis of gender.
OBJECTIVE: This study was designed to determine whether greater risk for anaphylactoid reaction caused by intravenous contrast media infusion exists in association with female gender.
METHODS: Rates of anaphylactoid and severe anaphylactoid reaction, according to gender, were determined in a sample of 5264 consecutive patients receiving conventional radiocontrast media during performance of computed tomography.
RESULTS: Of 80 adverse reactions caused by contrast media infusion, 73 (1.39%) were classified as anaphylactoid in nature. Among 5191 patients who received intravenous contrast media without experiencing an anaphylactoid reaction, there were 2642 male patients (51%) and 2549 female patients (49%); reactors included 22 male patients and 51 female patients (odds ratio = 2.40, 95% confidence interval = 1.42-4.10, p < 0.0005). Female patients also comprised 21 of 22 cases of severe anaphylactoid reaction (odds ratio = 21.77, 95% confidence interval = 3.13-435.12, p < 0.0005).
CONCLUSION: Greater risk for anaphylactoid and severe anaphylactoid reaction exists in association with female gender. Further studies are needed to identify mechanisms that can explain this risk. The importance of these findings for cost-effective use of lower osmolality contrast media need to be determined.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7722160     DOI: 10.1016/s0091-6749(95)70123-0

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  6 in total

Review 1.  Reactions to radiocontrast material. Anaphylactoid events in radiology.

Authors:  P L Lieberman; R L Seigle
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 8.667

2.  Safety of iobitridol in the general population and at-risk patients.

Authors:  Thomas J Vogl; Elmar Honold; Michael Wolf; H Mohajeri; R Hammerstingl
Journal:  Eur Radiol       Date:  2006-01-21       Impact factor: 5.315

3.  Contrast Medium Hypersensitivity: A Large Italian Study with Long-Term Follow-Up.

Authors:  Eleonora Nucera; Giuseppe Parrinello; Sebastiano Gangemi; Alessandro Buonomo; Arianna Aruanno; Franziska Michaela Lohmeyer; Riccardo Inchingolo; Angela Rizzi
Journal:  Biomedicines       Date:  2022-03-24

4.  Adverse reactions to contrast media: an analysis of spontaneous reports in the database of the pharmacovigilance programme of India.

Authors:  Vivekanandan Kalaiselvan; Surbhi Sharma; Gyanendra Nath Singh
Journal:  Drug Saf       Date:  2014-09       Impact factor: 5.606

5.  Emergent Premedication for Contrast Allergy Prior to Endovascular Treatment of Acute Ischemic Stroke.

Authors:  D A Tonetti; S M Desai; A Morrison; B A Gross; T G Jovin; B T Jankowitz; A P Jadhav
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-06       Impact factor: 3.825

6.  Differences between Drug-Induced and Contrast Media-Induced Adverse Reactions Based on Spontaneously Reported Adverse Drug Reactions.

Authors:  JiHyeon Ryu; HeeYoung Lee; JinUk Suh; MyungSuk Yang; WonKu Kang; EunYoung Kim
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.